Related references
Note: Only part of the references are listed.Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice
Maria del Carmen Parquet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Natural history of Acinetobacter baumannii infection in mice
Brian M. Luna et al.
PLOS ONE (2019)
Transient drug-tolerance and permanent drug-resistance rely on the trehalose-catalytic shift in Mycobacterium tuberculosis
Jae Jin Lee et al.
NATURE COMMUNICATIONS (2019)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Glutamate mediated metabolic neutralization mitigates propionate toxicity in intracellular Mycobacterium tuberculosis
Jae Jin Lee et al.
SCIENTIFIC REPORTS (2018)
Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
Maria del Carmen Parquet et al.
FRONTIERS IN MICROBIOLOGY (2018)
The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
Jeff Janes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Antibiotics in the clinical pipeline at the end of 2015
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2017)
Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
Travis B. Nielsen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine
Elisabeth Thulin et al.
EBIOMEDICINE (2017)
Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies
Travis B. Nielsen et al.
BMC MICROBIOLOGY (2015)
Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe
D. Brown et al.
EUROSURVEILLANCE (2015)
Resources for Genetic and Genomic Analysis of Emerging Pathogen Acinetobacter baumannii
Larry A. Gallagher et al.
JOURNAL OF BACTERIOLOGY (2015)
Validation of Antibiotic Susceptibility Testing Guidelines in a Routine Clinical Microbiology Laboratory Exemplifies General Key Challenges in Setting Clinical Breakpoints
Michael Hombach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Identification of Acinetobacter baumannii Serum-Associated Antibiotic Efflux Pump Inhibitors
Catlyn Blanchard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories
E. Matuschek et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Overcoming the current deadlock in antibiotic research
Till F. Schaeberle et al.
TRENDS IN MICROBIOLOGY (2014)
The FDA Reboot of Antibiotic Development
David M. Shlaes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2013)
Metabolic suppression identifies new antibacterial inhibitors under nutrient limitation
Soumaya Zlitni et al.
NATURE CHEMICAL BIOLOGY (2013)
Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis
Hyungjin Eoh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification and Characterization of an Outer Membrane Receptor Gene in Acinetobacter baumannii Required for Utilization of Desferricoprogen, Rhodotorulic Acid, and Desferrioxamine B as Xenosiderophores
Tatsuya Funahashi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes
Anna C. Jacobs et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)
Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection
Guanpingshen Luo et al.
PLOS ONE (2012)
Non-Traditional Antibacterial Screening Approaches for the Identification of Novel Inhibitors of the Glyoxylate Shunt in Gram-Negative Pathogens
Kelly C. Fahnoe et al.
PLOS ONE (2012)
Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis
Lin Lin et al.
MBIO (2012)
The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2008)
Drugs for bad bugs: confronting the challenges of antibacterial discovery
David J. Payne et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Share Paper
